Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Knobler

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
JAMA|July 22, 1988
Unique vascular skin lesions associated with human immunodeficiency virusE H Knobler, D N Silvers, K C Fine, et al.
QJM : Monthly Journal of the Association of Physicians|December 29, 2019
The characteristics of patients with possible familial hypercholesterolemia-screening a large payer/provider healthcare delivery systemA Elis, M Leventer-Roberts, A Bachrach, et al.
Journal De Physiologie|January 1, 1990
Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase geneY Groner, O Elroy-Stein, K B Avraham, et al.
Nephron|January 1, 1983
Multiple myeloma presenting as dense deposit disease. Light chain nephropathyH Knobler, J Kopolovic, Y Kleinman, et al.
Journal of the American Academy of Dermatology|January 11, 2003
Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease)Julian M Mackay-Wiggan, David J Cohen, Mark A Hardy, et al.
The American Journal of Medicine|October 1, 1987
HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndromeT Chajek-Shaul, S Pisanty, H Knobler, et al.
QJM : Monthly Journal of the Association of Physicians|April 21, 1999
Fatty liver--an additional and treatable feature of the insulin resistance syndromeH Knobler, A Schattner, T Zhornicki, et al.
Lancet (London, England)|January 9, 1982
Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infectionM Tobi, A Morag, Z Ravid, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Cell damage by excess CuZnSOD and Down's syndromeY Groner, O Elroy-Stein, K B Avraham, et al.
QJM : Monthly Journal of the Association of Physicians|August 19, 2007
Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in womenT Zornitzki, O Ayzenberg, G Gandelman, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
JAMA|July 22, 1988
Unique vascular skin lesions associated with human immunodeficiency virusE H Knobler, D N Silvers, K C Fine, et al.
QJM : Monthly Journal of the Association of Physicians|December 29, 2019
The characteristics of patients with possible familial hypercholesterolemia-screening a large payer/provider healthcare delivery systemA Elis, M Leventer-Roberts, A Bachrach, et al.
Journal De Physiologie|January 1, 1990
Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase geneY Groner, O Elroy-Stein, K B Avraham, et al.
Nephron|January 1, 1983
Multiple myeloma presenting as dense deposit disease. Light chain nephropathyH Knobler, J Kopolovic, Y Kleinman, et al.
Journal of the American Academy of Dermatology|January 11, 2003
Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease)Julian M Mackay-Wiggan, David J Cohen, Mark A Hardy, et al.
The American Journal of Medicine|October 1, 1987
HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndromeT Chajek-Shaul, S Pisanty, H Knobler, et al.
QJM : Monthly Journal of the Association of Physicians|April 21, 1999
Fatty liver--an additional and treatable feature of the insulin resistance syndromeH Knobler, A Schattner, T Zhornicki, et al.
Lancet (London, England)|January 9, 1982
Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infectionM Tobi, A Morag, Z Ravid, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Cell damage by excess CuZnSOD and Down's syndromeY Groner, O Elroy-Stein, K B Avraham, et al.
QJM : Monthly Journal of the Association of Physicians|August 19, 2007
Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in womenT Zornitzki, O Ayzenberg, G Gandelman, et al.
Pageof 6